文献速递产科母胎医学

关于遗传隐私的视频教育及患者对产前遗传数据共享的看法:一项随机试验

Video education about genetic privacy and patient perspectives about sharing prenatal genetic data: a randomized trial.
PubMed 文献 · Am J Obstet Gynecol · 2022-03-26

本研究为随机对照试验,纳入160例已行游离DNA检测并在孕17 0/7至23 6/7周行详细解剖超声的单胎妊娠患者,1:1随机分为对照组和干预组,两组均观看游离DNA信息图,干预组额外观看关于《遗传信息反歧视法》的教育视频。主要结局为对商业实验室共享产前遗传数据用于非临床用途的知识和共享意愿。结果显示视频教育未提高共享意愿,且干预组更可能错误认为数据不会被共享。

要点

  • 多数孕妇不知道游离DNA公司可能将产前遗传数据用于研究等非临床目的。
  • 观看《遗传信息反歧视法》教育视频未增加孕妇共享遗传数据的意愿。
  • 视频教育反而使干预组更可能错误认为数据不会被共享(对照组28.8% vs 干预组46.2%,P=.03)。

核心结论

  • 多数孕妇不知道其产前遗传数据可能被用于非临床目的。
  • 接受《遗传信息反歧视法》教育的孕妇并不比未接受教育者更愿意共享遗传数据。
  • 关于《遗传信息反歧视法》的视频教育使患者错误地认为其数据不会被共享用于研究,少数族裔参与者共享意愿更低。
  • 需要新策略改善孕妇对遗传隐私的理解。

研究设计与样本

  • 随机对照试验(ClinicalTrials.gov标识NCT04420858),纳入英语单胎妊娠、已行游离DNA检测并在孕17 0/7至23 6/7周行详细解剖超声的患者,1:1随机分为对照组和干预组。
  • 两组均观看游离DNA信息图,干预组额外观看关于《遗传信息反歧视法》的教育视频。
  • 筛查747例孕妇,213例符合条件并接触,163例(76.5%)同意并随机化;1例中止干预,2例干预后发现不符合全部入选标准而排除分析;最终分析160例(占接触者的75.1%)。
  • 每组需81例以达到80%把握度检测共享意愿从60%增至80%(α=0.05)。

主要发现

  • 对照组72例(90.0%)和干预组76例(97.4%)对游离DNA公司能否共享产前遗传数据用于研究表示不确定或错误认为不能共享。
  • 干预组比对照组更可能错误认为产前遗传数据不会被共享用于非临床目的(对照组28.8% vs 干预组46.2%,P=.03)。
  • 视频教育未提高参与者在多种场景下共享遗传数据的意愿。
  • 非白人参与者比白人参与者更不愿意允许共享遗传数据专门用于学术研究(P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laboratories offering cell-free DNA often reserve the right to share prenatal genetic data for research or even commercial purposes, and obtain this permission on the patient consent form. Although it is known that nonpregnant patients are often reluctant to share their genetic data for research, pregnant patients' knowledge of, and opinions about, genetic data privacy are unknown. OBJECTIVE: We investigated whether pregnant patients who had already undergone cell-free DNA screening were aware that genetic data derived from cell-free DNA may be shared for research. Furthermore, we examined whether pregnant patients exposed to video education about the Genetic Information Nondiscrimination Act-a federal law that mandates workplace and health insurance protections against genetic discrimination-were more willing to share cell-free DNA-related genetic data for research than pregnant patients who were unexposed. STUDY DESIGN: In this randomized controlled trial (ClinicalTrials.gov Identifier: NCT04420858), English-speaking patients with singleton pregnancies who underwent cell-free DNA and subsequently presented at 17 0/7 to 23 6/7 weeks of gestation for a detailed anatomy scan were randomized 1:1 to a control or intervention group. Both groups viewed an infographic about cell-free DNA. In addition, the intervention group viewed an educational video about the Genetic Information Nondiscrimination Act. The primary outcomes were knowledge about, and willingness to share, prenatal genetic data from cell-free DNA by commercial laboratories for nonclinical purposes, such as research. The secondary outcomes included knowledge about existing genetic privacy laws, knowledge about the potential for reidentification of anonymized genetic data, and acceptability of various use and sharing scenarios for prenatal genetic data. Eighty-one participants per group were required for 80% power to detect an increase in willingness to share data from 60% to 80% (α=0.05). RESULTS: A total of 747 pregnant patients were screened, and 213 patients were deemed eligible and approached for potential study participation. Of these patients, 163 (76.5%) consented and were randomized; one participant discontinued the intervention, and two participants were excluded from analysis after the intervention when it was discovered that they did not fulfill all eligibility criteria. Overall, 160 (75.1%) of those approached were included in the final analysis. Most patients in the control group (72 [90.0%]) and intervention (76 [97.4%]) group were either unsure about or incorrectly thought that cell-free DNA companies could not share prenatal genetic data for research. Participants in the intervention group were more likely to incorrectly believe that their prenatal genetic data would not be shared for nonclinical purposes than participants in the control group (28.8% in the control group vs 46.2% in the intervention; P=.03). However, video education did not increase participant willingness to share genetic data in multiple scenarios. Non-White participants were less willing than White participants to allow sharing of genetic data specifically for academic research (P<.001). CONCLUSION: Most participants were unaware that their prenatal genetic data may be used for nonclinical purposes. Pregnant patients who were educated about the Genetic Information Nondiscrimination Act were not more willing to share genetic data than those who did not receive this education. Surprisingly, video education about the Genetic Information Nondiscrimination Act led patients to falsely believe that their data would not be shared for research, and participants who identified as racial minorities were less willing to share genetic data. New strategies are needed to improve pregnant patients' understanding of genetic privacy.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Parobek CM, Thorsen MM, Has P, et al. Video education about genetic privacy and patient perspectives about sharing prenatal genetic data: a randomized trial. Am J Obstet Gynecol. 2022. PMID: 35351406. doi:10.1016/j.ajog.2022.03.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。